Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project

Marleen Kunneman1, Ellen M.A. Smets1, Femke H. Bouwman2, Niki S.M. Schoonenboom3, Marissa D. Zwan2, Ruth Pel-Littel4, Wiesje M. van der Flier2,5
1Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands
2Alzheimer Center and Department of Neurology, VU University Medical Center and Amsterdam Neuroscience, Amsterdam, The Netherlands
3Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands
4Vilans, Centre of Expertise for Long-term Care, Utrecht, the Netherlands
5department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands

Tóm tắt

AbstractIntroduction

This study explores clinicians' views on and experiences with when, how, and by whom decisions about diagnostic testing for Alzheimer's disease are made and how test results are discussed with patients.

Methods

Following a preparatory focus group with 13 neurologists and geriatricians, we disseminated an online questionnaire among 200 memory clinic clinicians.

Results

Respondents were 95 neurologists and geriatricians (response rate 47.5%). Clinicians (74%) indicated that decisions about testing are made before the first encounter, yet they favored a shared decision‐making approach. Patient involvement seems limited to receiving information. Clinicians with less tolerance for uncertainty preferred a bigger say in decisions (P < .05). Clinicians indicated to always communicate the diagnosis (94%), results of different tests (88%–96%), and risk of developing dementia (66%).

Discussion

Clinicians favor patient involvement in deciding about diagnostic testing, but conversations about decisions and test results can be improved and supported.


Tài liệu tham khảo

10.1016/j.jalz.2011.03.005 10.1212/WNL.0b013e3181eb5872 10.1016/j.jalz.2012.02.006 Gulbrandsen P., 2016, Shared decision‐making as an existential journey: aiming for restored autonomous capacity, Patient Educ Couns, 10.1016/j.pec.2016.07.014 10.1002/gps.1855 Petersen R.C., 2016, Mild cognitive impairment, Continuum (Minneapolis, Minn), 22, 404 10.1377/hlthaff.2015.1354 10.1111/acem.13065 Stacey D., 2014, Decision aids for people facing health treatment or screening decisions, Cochrane Database Syst Rev, 1, CD001431 10.1111/j.1532-5415.2011.03661.x 10.1093/geront/45.3.381 Karel M.J., 2010, Reasoning in the capacity to make medical decisions: the consideration of values, J Clin Ethics, 21, 58, 10.1086/JCE201021110 10.1017/S104161021400132X Miller L.M., 2014, Shared decision‐making in dementia: a review of patient and family carer involvement de Wilde A van Maurik IS Kunneman M et al. Alzheimer's Biomarkers In Daily Practice (ABIDE) project: rationale and design. Alzheimers Dement (Amst) (accepted). 10.1007/BF02250510 10.3109/0284186X.2015.1068447 Degner L.F., 1997, The Control Preferences Scale, Can J Nurs Res, 29, 21 10.1111/j.1369-7625.2004.00257.x 10.1016/j.pec.2009.09.034 Couet N., 2013, Assessments of the extent to which health‐care providers involve patients in decision making: a systematic review of studies using the OPTION instrument, Health Expect 10.1136/bmj.e256 10.1097/WAD.0b013e31817d5e4c 10.1136/bmj.317.7158.603b 10.1017/S1041610200006347 10.1056/NEJMp1510020 10.1111/j.1369-7625.2011.00717.x 10.1056/NEJMp1606402 IOM (Institute of Medicine) Crossing the Quality Chasm: A New Health System for the 21st Century. Washington D.C.2001.